Kitov Pharmaceuticals Holdings PE Ratio 2014-2018 | KTOV

Current and historical p/e ratio for Kitov Pharmaceuticals Holdings (KTOV) from 2014 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Kitov Pharmaceuticals Holdings PE ratio as of February 15, 2019 is 0.00.
Kitov Pharmaceuticals Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-02-15 1.13 inf
2018-06-30 2.64 0 0.00
2017-12-31 2.28 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.018B $0.001B
Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for OA. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $45.660B 30.37
Takeda Pharmaceutical (TAK) Japan $31.966B 11.83
Grifols (GRFS) Spain $13.614B 16.50
Ionis Pharmaceuticals (IONS) United States $8.114B 0.00
Neurocrine Biosciences (NBIX) United States $7.658B 496.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.596B 10.90
Sage Therapeutics (SAGE) United States $7.546B 0.00
Nektar Therapeutics (NKTR) United States $7.216B 10.35
Loxo Oncology (LOXO) United States $7.184B 0.00
Tilray (TLRY) United States $7.126B 0.00
Catalent (CTLT) United States $6.121B 25.63
United Therapeutics (UTHR) United States $5.214B 8.53
FibroGen (FGEN) United States $4.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.146B 13.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.102B 0.00
USANA Health Sciences (USNA) United States $2.519B 20.56
Endo (ENDP) Ireland $2.371B 3.63
Ironwood Pharmaceuticals (IRWD) United States $2.342B 0.00
Heron Therapeutics (HRTX) United States $2.155B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.082B 0.00
Portola Pharmaceuticals (PTLA) United States $2.057B 0.00
Xencor (XNCR) United States $2.050B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.005B 24.98
Zogenix (ZGNX) United States $1.972B 0.00
Aerie Pharmaceuticals (AERI) United States $1.898B 0.00
PTC Therapeutics (PTCT) United States $1.701B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.688B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.673B 226.00
Theravance Biopharma (TBPH) Cayman Islands $1.527B 0.00
Corcept Therapeutics (CORT) United States $1.363B 20.00
TherapeuticsMD (TXMD) United States $1.344B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.252B 0.00
Esperion Therapeutics (ESPR) United States $1.221B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.987B 0.00
Tricida (TCDA) United States $0.971B 0.00
ImmunoGen (IMGN) United States $0.842B 0.00
Radius Health (RDUS) United States $0.833B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.591B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.565B 0.00
Siga Technologies (SIGA) United States $0.562B 0.00
Karyopharm Therapeutics (KPTI) United States $0.559B 0.00
Flexion Therapeutics (FLXN) United States $0.555B 0.00
ChemoCentryx (CCXI) United States $0.554B 43.84
BioSpecifics Technologies Corp (BSTC) United States $0.521B 30.74
GlycoMimetics (GLYC) United States $0.513B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.512B 0.00
Collegium Pharmaceutical (COLL) United States $0.492B 0.00
Forty Seven (FTSV) United States $0.481B 0.00
Odonate Therapeutics (ODT) United States $0.443B 0.00
Aptorum Group (APM) China $0.431B 0.00
Translate Bio (TBIO) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.400B 0.00
Lannett Co Inc (LCI) United States $0.386B 3.58
Akebia Therapeutics (AKBA) United States $0.379B 0.00
ArQule (ARQL) United States $0.372B 0.00
KalVista Pharmaceuticals (KALV) United States $0.368B 0.00
HARPOON THERAPT (HARP) United States $0.354B 0.00
Concert Pharmaceuticals (CNCE) United States $0.352B 0.00
CASI Pharmaceuticals (CASI) United States $0.343B 0.00
Tyme Technologies (TYME) United States $0.330B 0.00
Dermira (DERM) United States $0.327B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.327B 0.00
Majesco Entertainment (PTE) United States $0.311B 0.00
OptiNose (OPTN) United States $0.305B 0.00
Aclaris Therapeutics (ACRS) United States $0.304B 0.00
Minerva Neurosciences (NERV) United States $0.297B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.285B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.281B 10.48
MARKER THERAPEUTICS, INC (MRKR) United States $0.246B 0.00
Mast Therapeutics (SVRA) United States $0.241B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
IMV INC (IMV) Canada $0.225B 0.00
Dova Pharmaceuticals (DOVA) United States $0.223B 0.00
MEI Pharma (MEIP) United States $0.216B 0.00
Aratana Therapeutics (PETX) United States $0.215B 0.00
Affimed (AFMD) Germany $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.211B 0.00
Calithera Biosciences (CALA) United States $0.204B 0.00
Aldeyra Therapeutics (ALDX) United States $0.204B 0.00
Xeris Pharmaceuticals (XERS) United States $0.203B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.198B 0.00
ElectroCore (ECOR) United States $0.195B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.195B 0.00
Recro Pharma (REPH) United States $0.186B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Redhill Biopharma (RDHL) Israel $0.179B 0.00
Molecular Templates (MTEM) United States $0.171B 0.00
Aquestive Therapeutics (AQST) United States $0.166B 0.00
Zafgen (ZFGN) United States $0.165B 0.00
Nature's Sunshine Products (NATR) United States $0.164B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.163B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.155B 0.00
Ocular Therapeutix (OCUL) United States $0.151B 0.00
Adherex Technologies (FENC) United States $0.151B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.148B 0.00
Neon Therapeutics (NTGN) United States $0.140B 0.00
Jounce Therapeutics (JNCE) United States $0.138B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.137B 0.00
Cardiome Pharma (CORV) Canada $0.134B 0.00
MediWound (MDWD) Israel $0.128B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.122B 0.00
DURECT (DRRX) United States $0.120B 0.00
China SXT Pharmaceuticals (SXTC) China $0.118B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.103B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.081B 0.00
Natural Alternatives (NAII) United States $0.080B 7.82
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
Infinity Pharmaceuticals (INFI) United States $0.079B 0.00
Melinta Therapeutics (MLNT) United States $0.077B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Forward Pharma (FWP) Denmark $0.065B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.063B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
Otonomy (OTIC) United States $0.062B 0.00
KemPharm (KMPH) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Genocea Biosciences (GNCA) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Achaogen (AKAO) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
Lipocine (LPCN) United States $0.036B 0.00
Capnia (SLNO) United States $0.036B 0.00
ContraFect (CFRX) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
NOVAN INC (NOVN) United States $0.031B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Biomerica (BMRA) United States $0.024B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Trillium Therapeutics (TRIL) Canada $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
VAXART, INC (VXRT) United States $0.014B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 1.19
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
Intellipharmaceutics (IPCI) Canada $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00